Abstract Details
|
Samuel Lichtman-Mikol, BA
(Wayne State University)
PRESENTER |
Mr. Lichtman-Mikol has nothing to disclose. |
| Kalyan Yarraguntla, MD (University Health Center) | Dr. Yarraguntla has nothing to disclose. |
| Melody Gilroy, BS | Ms. Gilroy has nothing to disclose. |
| Varun Chauhan, MD (Integris) | No disclosure on file |
| Elise Wiersma, NP (WSUPG) | No disclosure on file |
| Navid Seraji-Bozorgzad, MD (University of Michigan Medicine-Neurology) | No disclosure on file |
| Maysaa M. Basha, MD, FAAN (Wayne State University, Detroit Medical Center) | Dr. Basha has nothing to disclose. |
| Deepti Zutshi, MD, FAAN (Wayne State University School of Medicine) | Dr. Zutshi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Xenon pharmaceuticals. An immediate family member of Dr. Zutshi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Boston Scientific. Dr. Zutshi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Aucta Pharmaceuticals. Dr. Zutshi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Aucta. |
| Aashit K. Shah, MD, FAAN (Carilion Clinic) | Dr. Shah has stock in Abbot, Abbivie, Gilead, Johnson and Johnson, Pfizer. The institution of Dr. Shah has received research support from Xenon Pharma. |